{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:27:34Z","timestamp":1774513654187,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173946"],"award-info":[{"award-number":["82173946"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274066"],"award-info":[{"award-number":["82274066"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2019ZX09201004-002"],"award-info":[{"award-number":["2019ZX09201004-002"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["21ZR1460500"],"award-info":[{"award-number":["21ZR1460500"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jep.2023.116780","type":"journal-article","created":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T16:38:12Z","timestamp":1686501492000},"page":"116780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Study on the mechanism of Shuganzhi Tablet against nonalcoholic fatty liver disease and lipid regulation effects of its main substances in vitro"],"prefix":"10.1016","volume":"316","author":[{"given":"Jie","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengge","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaixia","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6454-876X","authenticated-orcid":false,"given":"Han","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2023.116780_bib1","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.3390\/molecules27228082","article-title":"Effects of sorafenib and quercetin alone or in combination in treating hepatocellular carcinoma: in vitro and in vivo approaches","volume":"27","author":"Abdu","year":"2022","journal-title":"Molecules"},{"issue":"2\u20133","key":"10.1016\/j.jep.2023.116780_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12013-007-0025-6","article-title":"PCK1 and PCK2 as candidate diabetes and obesity genes","volume":"48","author":"Beale","year":"2007","journal-title":"Cell Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.jep.2023.116780_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/chromsci\/bmw167","article-title":"Proteomics: technologies and their applications","volume":"55","author":"Bilal","year":"2017","journal-title":"J. Chromatogr. Sci."},{"issue":"1","key":"10.1016\/j.jep.2023.116780_bib4","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.90926.2008","article-title":"Acyl-coenzyme A:cholesterol acyltransferases","volume":"297","author":"Chang","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.jep.2023.116780_bib5","first-page":"82","article-title":"Treating 30 cases of hyperlipemia by liver-soothing fat-eliminating capsules","volume":"31","author":"Chen","year":"2018","journal-title":"West. J. Tradit. Chin. Med."},{"issue":"2","key":"10.1016\/j.jep.2023.116780_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab. Rev."},{"issue":"12","key":"10.1016\/j.jep.2023.116780_bib7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.tem.2016.09.001","article-title":"Perilipin 2 and age-related metabolic diseases: a new perspective","volume":"27","author":"Conte","year":"2016","journal-title":"Trends Endocrinol. Metabol."},{"issue":"7","key":"10.1016\/j.jep.2023.116780_bib8","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jep.2023.116780_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106865","article-title":"Bavachinin inhibits cholesterol synthesis enzyme FDFT1 expression via AKT\/mTOR\/SREBP-2 pathway","volume":"88","author":"Dong","year":"2020","journal-title":"Int. Immunopharm."},{"issue":"1","key":"10.1016\/j.jep.2023.116780_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13104-020-05094-2","article-title":"Aescin and diosmin each alone or in low dose-combination ameliorate liver damage induced by carbon tetrachloride in rats","volume":"13","author":"El-Dakhly","year":"2020","journal-title":"BMC Res. Notes"},{"issue":"2","key":"10.1016\/j.jep.2023.116780_bib11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.jep.2023.116780_bib12","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jep.2023.116780_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/ATVBAHA.117.309660","article-title":"\u0394-5 fatty acid desaturase FADS1 impacts metabolic disease by balancing proinflammatory and proresolving lipid mediators","volume":"38","author":"Gromovsky","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.jep.2023.116780_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/fca-2017-0019","article-title":"PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-\u03b2\/\u03b4 and PPAR-\u03b3","volume":"13","author":"Han","year":"2017","journal-title":"Future Cardiol."},{"issue":"12","key":"10.1016\/j.jep.2023.116780_bib15","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3390\/antiox9121173","article-title":"Hawthorn herbal preparation from crataegus oxyacantha attenuates in vivo carbon tetrachloride -induced hepatic fibrosis via modulating oxidative stress and inflammation","volume":"9","author":"Hamza","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.jep.2023.116780_bib16","first-page":"49","article-title":"34 cases of Shugan-Quzhi capsule in the treatment of fatty liver with liver function damage","volume":"1","author":"Hong","year":"2002","journal-title":"Chin. J. Inf. Tradit. Chin. Med."},{"issue":"2","key":"10.1016\/j.jep.2023.116780_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF03256448","article-title":"Role of cholesterol 7alpha-hydroxylase (CYP7A1) in nutrigenetics and pharmacogenetics of cholesterol lowering","volume":"10","author":"Hubacek","year":"2006","journal-title":"Mol. Diagn. Ther."},{"issue":"1","key":"10.1016\/j.jep.2023.116780_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.dsx.2014.09.015","article-title":"PPAR gamma gene--a review","volume":"9","author":"Janani","year":"2015","journal-title":"Diabetes Metabol. Syndr."},{"issue":"9","key":"10.1016\/j.jep.2023.116780_bib19","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/j.apsb.2022.05.001","article-title":"Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: a promising drug Potentilla discolor Bunge","volume":"12","author":"Ji","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.jep.2023.116780_bib20","first-page":"238","article-title":"Study on the effect of Shugan Quzhi Capsule in rats of experimental liver steatosis","volume":"24","author":"Jin","year":"2015","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"issue":"6","key":"10.1016\/j.jep.2023.116780_bib21","doi-asserted-by":"crossref","first-page":"11963","DOI":"10.3390\/ijms140611963","article-title":"In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD)","volume":"14","author":"Kanuri","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.jep.2023.116780_bib22","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.celrep.2016.02.037","article-title":"The P72R polymorphism of p53 predisposes to obesity and metabolic dysfunction","volume":"14","author":"Kung","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jep.2023.116780_bib23","article-title":"Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism","volume":"144","author":"Kuwata","year":"2019","journal-title":"Prostag. Other Lipid Mediat."},{"issue":"10","key":"10.1016\/j.jep.2023.116780_bib24","first-page":"1819","article-title":"Study on quality standard of Shuganzhi tablets","volume":"33","author":"Li","year":"2011","journal-title":"Chin. Tradit. Pat. Med."},{"issue":"5","key":"10.1016\/j.jep.2023.116780_bib25","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/ATVBAHA.119.312136","article-title":"Lysosomal acid lipase in lipid metabolism and beyond","volume":"39","author":"Li","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jep.2023.116780_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112442","article-title":"Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula","volume":"251","author":"Li","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2023.116780_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109734","article-title":"Huang-Qi San improves glucose and lipid metabolism and exerts protective effects against hepatic steatosis in high fat diet-fed rats","volume":"126","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jep.2023.116780_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2022.111420","article-title":"EPA and DHA inhibit endocytosis of claudin-4 and protect against deoxynivalenol-induced intestinal barrier dysfunction through PPAR\u03b3 dependent and independent pathways in jejunal IPEC-J2 cells","volume":"157","author":"Li","year":"2022","journal-title":"Food Res. Int."},{"key":"10.1016\/j.jep.2023.116780_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109199","article-title":"High fat diet-triggered non-alcoholic fatty liver disease: a review of proposed mechanisms","volume":"330","author":"Lian","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"12","key":"10.1016\/j.jep.2023.116780_bib30","doi-asserted-by":"crossref","first-page":"890","DOI":"10.5246\/jcps.2017.12.099","article-title":"The clinical effect and safety evaluation of Shugan Quzhi capsule in the treatment of adult simple obesity","volume":"26","author":"Lin","year":"2017","journal-title":"J. Chin. Pharmaceut. Sci."},{"key":"10.1016\/j.jep.2023.116780_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118629","article-title":"Metabolomic-proteomic combination analysis reveals the targets and molecular pathways associated with hydrogen sulfide alleviating NAFLD","volume":"264","author":"Liu","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.jep.2023.116780_bib32","article-title":"Changes of the fatty acid profile in erythrocyte membranes of patients following 6-month dietary intervention aimed at the regression of nonalcoholic fatty liver disease (NAFLD)","volume":"2018","author":"Maciejewska","year":"2018","journal-title":"Chin. J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.jep.2023.116780_bib33","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.dsx.2019.03.009","article-title":"Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: a cross-sectional study in north of Iran","volume":"13","author":"Mansour-Ghanaei","year":"2019","journal-title":"Diabetes Metabol. Syndr."},{"issue":"4","key":"10.1016\/j.jep.2023.116780_bib34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s13105-011-0110-6","article-title":"Role of lipid droplet proteins in liver steatosis","volume":"67","author":"Okumura","year":"2011","journal-title":"J. Physiol. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.jep.2023.116780_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11010-016-2737-7","article-title":"Fads1 and 2 are promoted to meet instant need for long-chain polyunsaturated fatty acids in goose fatty liver","volume":"418","author":"Osman","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jep.2023.116780_bib36","series-title":"Great Dictionary of TCM Prescriptions","first-page":"317","author":"Peng","year":"1996"},{"key":"10.1016\/j.jep.2023.116780_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.plipres.2016.09.003","article-title":"DHCR7: a vital enzyme switch between cholesterol and vitamin D production","volume":"64","author":"Prabhu","year":"2016","journal-title":"Prog. Lipid Res."},{"issue":"7","key":"10.1016\/j.jep.2023.116780_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180856","article-title":"Functional analysis of the zebrafish ortholog of HMGCS1 reveals independent functions for cholesterol and isoprenoids in craniofacial development","volume":"12","author":"Quintana","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jep.2023.116780_bib39","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/01.ATV.0000166548.65753.1e","article-title":"ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia","volume":"25","author":"Rudel","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.jep.2023.116780_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/JOE-11-0315","article-title":"The diversity of sex steroid action: novel functions of hydroxysteroid (17\u03b2) dehydrogenases as revealed by genetically modified mouse models","volume":"212","author":"Saloniemi","year":"2012","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.jep.2023.116780_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.jep.2023.116780_bib42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mam.2018.03.001","article-title":"Omega-3 fatty acids and non-alcoholic fatty liver disease: evidence of efficacy and mechanism of action","volume":"64","author":"Scorletti","year":"2018","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.jep.2023.116780_bib43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.freeradbiomed.2019.05.029","article-title":"Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease","volume":"144","author":"Svegliati-Baroni","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jep.2023.116780_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122827","article-title":"Metabolite profiling of Shuganzhi tablets in rats and pharmacokinetics study of four bioactive compounds with liquid chromatography combined with electrospray ionization tandem mass spectrometry","volume":"1179","author":"Tang","year":"2021","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"9","key":"10.1016\/j.jep.2023.116780_bib45","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.bbadis.2012.02.010","article-title":"Peroxisomal acyl-CoA synthetases","volume":"1822","author":"Watkins","year":"2012","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"2","key":"10.1016\/j.jep.2023.116780_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201800536","article-title":"Taurine is involved in energy metabolism in muscles, adipose tissue, and the liver","volume":"63","author":"Wen","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"issue":"5","key":"10.1016\/j.jep.2023.116780_bib47","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s10517-021-05285-2","article-title":"Taurine reduces liver damage in non-alcoholic fatty liver disease model in rats by down-regulating IL-9 and tumor growth factor TGF-\u03b2","volume":"171","author":"Yao","year":"2021","journal-title":"Bull. Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.jep.2023.116780_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.jep.2023.116780_bib49","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"}],"updated-by":[{"DOI":"10.1016\/j.jep.2024.119167","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000}}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874123006487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874123006487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T21:40:17Z","timestamp":1733866817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874123006487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":49,"alternative-id":["S0378874123006487"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2023.116780","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jep.2024.119167","asserted-by":"object"}]},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study on the mechanism of Shuganzhi Tablet against nonalcoholic fatty liver disease and lipid regulation effects of its main substances in vitro","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2023.116780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116780"}}